Clinical and immunologic evidence suggests that tuberculous pleuritis provides a model to understand protective immune mechanisms against Mycobacterium tuberculosis. We therefore evaluated the pattern of cytokine mRNA expression and cytokine production in pleural fluid and blood of patients with tuberculous pleuritis. RNA was extracted from mononuclear cells, reverse transcribed to cDNA, and amplified by polymerase chain reaction (PCR). After normalization for T-cell cDNA, cDNA from pleural fluid cells and peripheral blood mononuclear cells (PBMC) was amplified with cytokine-specific primers. PCR product was quantified by Southern blot. For the Thl cytokines gamma interferon (IFN-y) and interleukin-2 (IL-2), PCR product was greater in pleural fluid than in blood, whereas PCR product for the Th2 cytokine IL-4 was 
Tuberculosis, long regarded as a declining disease soon to be relegated to the pages of medical history, is back with a vengeance. The worldwide epidemic of human immunodeficiency virus infection has created a large population with extraordinary susceptibility to Mycobacterium tuberculosis, and tuberculosis case rates have risen dramatically in regions where human immunodeficiency virus infection is widespread, including many parts of the United States (3, 6) . Recent outbreaks of multidrug-resistant disease (13) underscore the need for novel approaches to treat and prevent tuberculosis, including the use of immunotherapeutic modalities that enhance normal antimycobacterial defenses. Development of such strategies requires a more detailed understanding of the human immune response to M. tuberculosis, including definition of the T-cell subpopulations and cytokines that mediate resistance to tuberculous infection.
Immunologic resistance to mycobacterial infection is thought to be mediated by cooperative interaction between T lymphocytes and macrophages. This interaction is dependent upon the interplay of cytokines produced by a variety of mononuclear cells, but predominantly by T cells. The specific cytokines that mediate immunologic resistance to mycobacteria in humans remain undefined. Although most evidence favors a dominant role for the Thl cytokines gamma interferon (IFN-y) and interleukin-2 (IL-2) (16, 25, 43, 49) , other data suggest that a broad spectrum of cyto-* Corresponding author.
kines may contribute to antimycobacterial immune defenses (5, 12) .
Clinical and immunologic evidence suggests that tuberculous pleuritis provides a model to understand immune mechanisms potentially protective against M. tuberculosis. Unlike the case in most other forms of tuberculosis, pleuritis usually resolves without chemotherapy (42) , suggesting that local cell-mediated immune responses result in effective clearance of bacilli. CD4+ T cells are selectively concentrated in the pleural space of patients with tuberculous pleuritis, and these T cells proliferate and secrete IFN-'y specifically in response to M. tuberculosis (10, 11, 47) . To gain insight into the patterns of cytokine secretion that contribute to antimycobacterial defenses in vivo, we evaluated cytokine production in patients with tuberculous pleuritis.
MATERIALS AND METHODS
Patient population. Pleural fluid and blood were obtained from 12 Validity of PCR amplification for semiquantitative determination of cytokine mRNA expression. Plasmids containing IFN--y, IL-2, IL-4, and IL-10 cDNAs were serially diluted in 10-fold increments, and visualization by ethidium bromide staining indicated that the lower limit of detectability was in the order of 102 to 103 copies for each cytokine (51, 52) . The intensity of PCR product increased according to the number of copies of starting plasmid up to 109 copies. These PCR products were transferred to nylon membrane, probed, and quantified by radioanalytic imaging. There was a log-linear relationship between the number of starting copies and the quantity of PCR product throughout the range investigated. These results indicate that the PCR conditions employed provide meaningful comparisons of small amounts of cytokine mRNA.
A number of controls were employed to ensure accurate comparison of the different samples studied. Upon PCR amplification of serial 10-fold dilutions of sample cDNAs, a concomitant decrease in the PCR product was observed. Variation of the number of PCR cycles did not change the relative differences between samples. These studies indicate that our PCR conditions are not within the plateau phase of amplification. Mixing of cDNAs from different patients did not inhibit or augment PCR amplification, indicating that sample cDNAs did not directly alter the efficiency of PCR amplification. Each experiment included a positive control (cDNA from phytohemagglutinin-stimulated PBMC) and a negative control to which no cDNA was added. In addition, precautions were taken to avoid cross-contamination of samples, including assembling reactions in laminar flow hoods, using aliquot portions of reagents, using pipettes designated for assembling PCR reactions, and using aerosolresistant pipette tips (Continental Lab Products, La Jolla, Calif.).
Stimulation of mononuclear cells with M. tuberculosis. Pleural fluid mononuclear cells or PBMC, 2 x 106, were obtained by centrifugation over Ficoll-Plaque (Pharmacia) and suspended in 2-ml wells, each containing 10 ,ug of M. tuberculosis per ml, 10% human serum, and RPMI (GIBCO) with penicillin and streptomycin (GIBCO). Control wells contained no antigen. Cells were maintained at 37°C and 7.5% CO2. After 24 h, mononuclear cells were collected, lysed with guanidinium isothiocyanate, and stored at -20°C prior to preparation of cDNA. Cytocentrifuge preparations were made in some cases by standard techniques (28) .
Cell culture supernatants were harvested after 24 h and stored at -70°C for measurement of cytokine concentrations. The cytokine concentration induced by M. tuberculosis was calculated as that measured in the appropriate supernatant minus the cytokine concentration in control wells containing media alone.
Measurement of cytokine concentrations. Cytokine concentrations were measured in pleural fluid, serum, and cell culture supernatants. Pleural fluid and blood were centri- fuged at 1,300 x g for 10 min, and supernatants were stored at -70°C. Supernatants from cell cultures were collected as outlined above. Concentrations of IFN--y, IL-2, IL-4, IL-5, and IL-10 were measured by enzyme-linked immunosorbent assay (ELISA) (4, 17) .
In situ hybridization. Cytocentrifuge preparations of cells cultured with mycobacterial preparations or media alone were subjected to in situ hybridization to detect mRNA for IFN--y, as described previously (8, 14) . Each sample was hybridized with the sense probe (homologous to cellular mRNA) and the antisense probe (complementary to cellular mRNA). mRNA for IFN--y hybridized with the antisense probe, while the sense probe was unhybridizable and served as a negative control. In each experiment, samples known from prior studies to be positive or negative for IFN--y mRNA expression were used as controls. Cells were considered positive for expression of cytokine mRNA when they contained greater than twice the number of grains of the most positive cell on the slide of the same preparation to which the sense probe had been added. 
RESULTS
Cytokine mRNA expression by pleural fluid mononuclear cells. To investigate the pattern of cytokines produced at the site of tuberculous infection, we compared cytokine mRNA expression in freshly isolated pleural fluid mononuclear cells and PBMC of patients with tuberculous pleuritis. Because the cytokines we evaluated were likely to be produced by T cells, we used equivalent amounts of T-cell cDNA from pleural fluid and blood samples of each patient. cDNA from both sources were serially diluted, and CD3 b-chain cDNA was amplified by PCR and then hybridized to radiolabeled probe. Results of normalization for samples from six patients are shown in Table 1 . PCR amplification and hybridization of serial dilutions of sample cDNA revealed a log-linear relationship between the amount of substrate cDNA and radioactivity incorporation (data not shown).
After normalization for T-cell cDNA, cDNA from pleural fluid cells and PBMC was amplified with primers specific for the cytokines IFN--y, IL-2, lymphotoxin, IL-4, IL-5, and IL-10. Hybridization of PCR product to radiolabeled probes revealed significant differences between cytokine mRNA in pleural fluid mononuclear cells and in PBMC. For the cytokines characteristically produced by Thl cells, radioactivity incorporation representative of mRNA for IFN--y and IL-2 was greater in pleural fluid cells than in PBMC (Fig. 1A and B), whereas the amounts of mRNA for lymphotoxin were similar in pleural fluid cells and PBMC (Fig. 1C ). Only patient 6 showed no increased expression of mRNA for IFN-y or IL-2 mRNA in pleural fluid cells. This patient was not clinically distinguishable from the other five patients. For cytokines characteristically produced by Th2 cells, radioactivity incorporation representative of mRNA for IL-4 was decreased in pleural fluid cells compared with PBMC ( Fig. 2A) . mRNA for IL-5 was barely detectable (Fig. 2B) , and expression of IL-10 mRNA was variable in pleural fluid cells and PBMC (Fig. 2C) . Mean values for radioactivity incorporation representative of mRNA for cytokines in pleural fluid cells and PBMC are shown in Table 2 . All PCR amplification and hybridization experiments for a given cytokine were performed at the same time.
PCR amplification of cytokine cDNA in plasmids. To confirm that the differences observed in radioactivity incorporation by PCR product represented quantitative differences in substrate cDNA, we compared results of PCR amplification and hybridization of patient samples with parallel results obtained by amplification of plasmids containing known copy numbers of cDNA for IFN--y, IL-2, and IL-10. Hybridization of PCR product for the samples and plasmids was performed at the same time. For plasmids containing IFN--y, the relationship between copy number of IFN--y cDNA and radioactivity incorporation was log-linear for amplification of 10 to 109 copies (Fig. 3) . The values obtained for radioactivity incorporation by IFN--y cDNA PCR product from the samples ranged from 230 to 2,259 cpm, which was within the linear range of PCR amplification. These results indicate that the greater radioactivity incorporation representative of IFN--y mRNA in pleural fluid versus blood reflected differences in substrate IFN--y mRNA in these compartments. Similar experiments with plasmids containing IL-2 and IL-10 cDNA indicated that radioactivity incorporation by PCR product from the samples was within the linear range of PCR amplification (data not shown).
Cytokine concentrations in pleural fluid and serum. To determine whether the pattern of selective cytokine mRNA concentration in pleural fluid cells reflected cytokine production at the site of disease, we measured concentrations of IFN-y, IL-2, IL-4, IL-5, and IL-10 in pleural fluid and serum of seven patients. In confirmation of previously published results, IFN-y concentrations were markedly elevated in pleural fluid (mean, 1,178 pg/ml), but not detectable in serum (P < 0.01; Figure 4A Expression of IL-10 mRNA by macrophages. IL-10 can be produced by Thl cells, Th2 cells, or macrophages (15, 17, 53) . Because IL-10 concentrations were elevated in pleural fluid, but IL-10 mRNA expression was similar in pleural fluid cells and PBMC after normalization for T-cell mRNA content, we hypothesized that IL-10 was not produced predominantly by T cells. We therefore renormalized pleural fluid and blood samples for total mRNA content, using P-actin as a marker. After normalization, samples were amplified with primers specific for IL-10 and hybridized to radiolabeled probe. Radioactivity incorporation representative of IL-10 mRNA was greater in pleural fluid cells than in PBMC (mean, 1,094 versus 656 cpm; P = 0.0002) (Fig. 5) . To determine the source of IL-10 mRNA, freshly isolated pleural fluid cells were separated into CD3+ and CD3-populations by immunomagnetic selection of CD3+ cells. By PCR amplification, IL10 mRNA was detected predominantly in CD3-but not CD3+ cells. IL-10 mRNA was also detectable in CD14+ pleural fluid cells, indicating that IL-10 mRNA is expressed predominantly by macrophages.
Cytokine production in response to M. tuberculosis. Failure to detect IL-2, IL-4, and IL-5 in pleural fluid and serum may result from uptake of these cytokines by pleural fluid or blood cells. As an alternative means to assess whether the selective cytokine mRNA expression in pleural fluid and blood reflected translation into active cytokine in response to mycobacterial antigen, we measured cytokine concentrations in pleural fluid mononuclear cells and PBMC of six patients stimulated in vitro with M. tuberculosis Erdman. Mean concentrations of IFN-y produced by pleural fluid cells were significantly higher than those produced by PBMC (mean, 9,180 versus 1,537 pg/ml; P = 0.002) (Fig. 6A) . Similar findings were noted for concentrations of IL-2 (mean, 688 versus 16 pg/ml; P = 0.001) (Fig. 6B) . In five of six cases, PBMC produced more IL-10 than did pleural fluid cells (Fig. 6C ), but this difference did not achieve statistical significance (P = 0.07). IL-4 and IL-5 were not detectable in any of the supernatants tested. Frequency of cells that produce IFN-y. To determine whether the higher concentration of IFN-y in stimulated pleural fluid cells was due to a higher frequency of antigenreactive cytokine-producing cells, in situ hybridization was performed on cytocentrifuge preparations of pleural fluid cells and PBMC cocultured with M. tuberculosis Erdman. The frequency of cytokine mRNA-expressing cells was 20-to 60-fold higher in pleural fluid than in blood (P = 0.0007) (Fig. 7) .
DISCUSSION
The data presented in this report provide strong evidence for compartmentalization of Thl cytokines and IL-10 at the site of disease in humans with a resistant immune response to M. tuberculosis. Expression of mRNA for IFN--y and IL-2 was greater in pleural fluid than in blood of patients with tuberculous pleuritis, and concentrations of IFN-y were 15-fold higher in pleural fluid than in serum. Pleural fluid lymphocytes stimulated with M. tuberculosis produced substantially higher concentrations of IFN--y and IL-2 than did peripheral blood lymphocytes, and the frequency of cells expressing IFN-,y mRNA was 20-to 60-fold higher in pleural fluid than in blood. IL-10 produced by macrophages was also selectively concentrated in the pleural space and may serve to downregulate the local immune response.
Immunologic resistance and susceptibility to intracellular pathogens in mice are thought to be mediated by CD4+ T cells with specific patterns of cytokine secretion. Thl cells that produce IFN-y confer resistance to infection with Leishmania sp. (26, 45) , Candida sp. (41) , and Schistosoma mansoni (20, 39, 40) , whereas Th2 cells that produce IL-4 may mediate protective immunity against Trichinella spiralis and Trichuris muris (19, 24 clones cultured in vitro may not reflect events in vivo, it is critical to evaluate the cytokine response at the site of mycobacterial disease. Studies in leprosy indicate that mRNA for IFN--y and IL-2 is highest in tuberculoid leprosy patients with a relatively resistant immune response, whereas expression of mRNA for IL-4, IL-5, and IL-10 predominates in lepromatous leprosy patients with ineffective immunity (51) . It remains uncertain from these studies whether the predominance of Thl cytokines in tissue lesions of tuberculoid leprosy patients reflects dominance of Thl cells in blood of these patients or results from compartmentalization of Thl cells in tissue lesions. Our current findings suggest that selective concentration of Thl cells predominates at the site of disease in patients with a resistant immune response to mycobacterial infection.
Enhanced production of IFN--y and IL-2 in the pleural space is likely to contribute to immune defenses against M. tuberculosis. IFN--y enhances antimycobacterial activity of murine macrophages (22) , probably through increased production of reactive nitrogen metabolites (23) , and IFN-y production is a functional marker of murine T cells that confer adoptive immunity against M. bovis and M. tuberculosis (30, 37) . Although the capacity of IFN--y to enhance antimycobacterial activity by human macrophages in vitro remains controversial (18, 46) , administration of this cytokine reduced the bacillary burden in patients with lepromatous leprosy (36) . IL-2 may also facilitate mycobacterial elimination through its activity as a potent T-cell growth and activation factor that further increases the local concentration of macrophage-activating factors such as IFN--y.
Because IL-4 deactivates macrophages (2, 27, 31, 38) and blocks T-cell proliferation by downregulation of IL-2 receptor expression (34) , the relative absence of IL-4 in the pleural space may enhance host immune defenses. Exclusion of IL-4 may also explain the relatively low concentration of immunoglobulin in pleural fluid despite the hyperglobulinemia in serum of tuberculosis patients (32) .
In contrast to findings for IL-4, IL-10 was detectable in pleural fluid and IL-10 mRNA was expressed predominantly by macrophages, which may produce IL-10 in response to high local concentrations of mycobacterial antigens such as lipoarabinomannan (7) . IL-10 may inhibit synthesis of cytokines such as tumor necrosis factor alpha by macrophages (17) and IFN--y by T cells (21, 35) , which may otherwise result in a marked inflammatory response and tissue damage. The human immune response to infectious agents is often a double-edged sword that contributes to elimination of pathogens but may also be harmful to host cells. In pleural tuberculosis, the inflammatory response effectively eliminates mycobacteria but produces large pleural effusions, fever, chest pain, and shortness of breath. It is intriguing to speculate that IFN--y, a prominent cytokine in the pleural space, contributes to cell-mediated immunity through macrophage activation, as well as to immunopathology through enhancement of production of tumor necrosis factor, which in turn causes fever and tissue necrosis. In support of this hypothesis, concentrations of tumor necrosis factor are elevated in pleural fluid of patients with tuberculous pleuritis (8) , and administration of IFN--y to lepromatous leprosy patients enhances mycobacterium-induced tumor necrosis factor production, resulting in fever, malaise, and weight loss (44) . Further studies of the local immune response in human tuberculosis will enhance our understanding of the complex host-pathogen interaction and facilitate development of immunomodulatory therapy to reduce morbidity and mortality from this disease.
